Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu, Sony DADC Extend MALDI Collaboration

NEW YORK (GenomeWeb News) – Shimadzu and Sony DADC have extended a collaboration to develop application-specific, individually barcoded, disposable MALDI targets for regulated and non-regulated markets.

The alliance involves Shimadzu's wholly owned subsidiary Kratos Analytical and is focused on developing MALDI products for new application areas where targets can be given application-specific properties. The firms have collaborated over the past four years and developed the Fleximass DS disposable MALDI targets, which has been applied to forensics and imaging workflows.

"As we move into increasingly regulated markets such as medical devices, the need for labs to cost-effectively eliminate the possibility of cross-contamination, and to ensure a robust audit trail, means that it will no longer be possible to use the old style of re-usable metal MALDI targets," Kozo Shimazu, managing director of Kratos Analytical, said in a statement released yesterday.

Further terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more